Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Bomedemstat (IMG-7289), an LSD1 Inhibitor, Manages the Signs and Symptoms of Essential Thrombocythemia (ET) While Reducing the Burden of Cells Homozygous for Driver Mutations

Blood (2023) 142 (Supplement 1): 747.

https://doi.org/10.1182/blood-2023-179329

Published: 2023

Journal Articles

Real World, Single-Centre Experience of Pregnancy in Patients with Philadelphia Negative Myeloproliferative Neoplasms

Holly Theaker, Jonathan Lambert, Donal P McLornan, Andrew J. Wilson, Syeda Ahmed, Aisha Roble, Samah Alimam

Blood (2023) 142 (Supplement 1): 6391.

https://doi.org/10.1182/blood-2023-189297

Published: 2023

Journal Articles

The Use of Targeted RNA- Sequencing Assay in the Diagnostic Evaluation of Acute Myeloid Leukaemia(AML)

Shweta Gupta, Eleanor Kaffo, Robert Baker, Elisabeth Nacheva, Jenny O'Nions, Andrew J. Wilson, Rajeev Gupta, Ke Xu

Blood (2023) 142 (Supplement 1): 5829.

https://doi.org/10.1182/blood-2023-178319

Published: 2023

Journal Articles

Chromoanagenesis in Haematological Malignancy: Review of Samples from Patients with Acute Leukemia and MDS

Elisabeth P Nacheva, Temenuzhka Boneva, Jenny O'Nions, Andrew J. Wilson, Ke Xu, Robert Baker, Rajeev Gupta

Blood (2023) 142 (Supplement 1): 1564.

https://doi.org/10.1182/blood-2023-186105

Published: 2023

Journal Articles

A Real World, Single-Centre Study of Young Adult Patients with Philadelphia Negative Myeloproliferative Neoplasms

Dipal Mehta, Holly Theaker, Donal P McLornan, Jonathan Lambert, Andrew J. Wilson, Hugo Ferreira, Syeda Ahmed, Aisha Roble, Samah Alimam

Blood (2023) 142 (Supplement 1): 6402.

https://doi.org/10.1182/blood-2023-189502

Published: 2023

Journal Articles

A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET)

Blood (2022) 140 (Supplement 1): 1784–1787.

https://doi.org/10.1182/blood-2022-159047

Published: 2022

Journal Articles

The Use of Avapritinib in Advanced Systemic Mastocytosis: Report of an Open-Label Compassionate Use Program in the United Kingdom

Christopher J. Saunders, Chandan Saha, Priya Sriskandarajah, Helen Cashman, Andrew J Wilson, Jonathan Lambert, Matthew Lawes, David Tucker, Simone Green, Manish Jain, Victoria Stables, Juanah Addada, Theingi Yin, Huw Roddie, Bethan Psaila, Deepti H. Radia

Blood (2022) 140 (Supplement 1): 3976–3977.

https://doi.org/10.1182/blood-2022-166073

Published: 2022

Journal Articles

Single Centre Analysis of JAK2 V617F and Exon 12 Negative Idiopathic Erythrocytosis

Kushani Ediriwickrema, Andrew J Wilson, Jenny O'Nions, Mallika Sekhar, Syeda Ahmed, Aisha Roble, Emma Louise Shambrook, Jonathan Lambert, Samah Alimam

Blood (2021) 138 (Supplement 1): 4620.

https://doi.org/10.1182/blood-2021-152361

Published: 2021

Journal Articles

EDIT-301: An Experimental Autologous Cell Therapy Comprising Cas12a-RNP Modified mPB-CD34+ Cells for the Potential Treatment of SCD

Edouard De Dreuzy, PhD, Jack Heath, John A Zuris, PhD, Patricia Sousa, Ramya Viswanathan, Sean Scott, Jen Da Silva, Terence Ta, PhD, Stacy Capehart, PhD, Tongyao Wang, Cecilia Fernandez, PhD, Vic E Myer, PhD, Charles F Albright, PhD, Christopher J Wilson, PhD, Sandra Teixeira, PhD, Kai-Hsin Chang, PhD

Blood (2019) 134 (Supplement_1): 4636.

https://doi.org/10.1182/blood-2019-130256

Published: 2019

Journal Articles

Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation Model

Blood (2018) 132 (Supplement 1): 409.

https://doi.org/10.1182/blood-2018-99-114780

Published: 2018

Journal Articles

Inhibiting TGFβ Signaling in CAR T-Cells May Significantly Enhance Efficacy of Tumor Immunotherapy

Blood (2017) 130 (Supplement 1): 1791.

https://doi.org/10.1182/blood.V130.Suppl_1.1791.1791

Published: 2017

Journal Articles

Design, Optimization, and Pre-Clinical Evaluation of Direct, Mechanism-Based STAT3 Inhibitors for Treating Myeloid Disorders

William L. Heaton, M.S., Anna M. Eiring, PhD, Nadeem A. Vellore, PhD, Diana Resetca, B.S., Sina Haftchenary, PhD, David Rosa, PhD, Ahmed M. Ali, Anna V. Senina, M.S., Anthony D. Pomicter, M.S., Brent D.G. Page, PhD, Ira L. Kraft, B.S., Kimberly R. Reynolds, M.S., Derek J. Wilson, PhD, Riccardo Baron, PhD, Thomas O'Hare, PhD, Patrick T. Gunning, PhD, Michael W. Deininger

Blood (2014) 124 (21): 4816.

https://doi.org/10.1182/blood.V124.21.4816.4816

Published: 2014

Journal Articles

Dysregulation of the Imprinted DLK1-DIO3 Locus in Promyelocytic Leukemia

Maria Trissal, BS, David H Spencer, MD/PhD, Jessica Silva, PhD, Todd Wylie, BS, Jasreet Hundal, MS, Sean McGrath, MS, Vincent Magrini, PhD, Giridharan Ramsingh, Richard J Wilson, PhD, Timothy J. Ley, MD, Daniel C. Link

Blood (2012) 120 (21): 3500.

https://doi.org/10.1182/blood.V120.21.3500.3500

Published: 2012

Journal Articles

Hoxa9 Suppresses Cellular Senescence and Sustains the Development of Leukemic Stem Cells Induced by Fusion Proteins In the Absence of Bmi1.

Lan-Lan Smith, Jenny Yeung, PhD, Bernd B Zeisig, PhD, Ivo Huijbers, PhD, Nik Popov, PhD, Josephine Barnes, PhD, Amanda J Wilson, Sanne Lugthart, PhD, Ruud Delwel, PhD, Jesus Gil, PhD, Maarten van Lohuizen, PhD, Chi Wai Eric So, PhD

Blood (2010) 116 (21): 1578.

https://doi.org/10.1182/blood.V116.21.1578.1578

Published: 2010

Journal Articles

FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection

Timothy J. Wilson, Rachel M. Presti, Ilaria Tassi, Edgar T. Overton, Marina Cella, Marco Colonna

Blood (2007) 109 (9): 3786–3793.

https://doi.org/10.1182/blood-2006-06-030023

Published: 2007

Includes: Supplemental data

Journal Articles

Recruitment of RXRα by Homo-Oligomeric RARα Is a Key for RARα-Mediated Transformation.

Bernd B. Zeisig, PhD, Colin Kwok, PhD, Amanda J. Wilson, BSc, Arthur Zelent, PhD, Hinrich Gronemeyer, PhD, Shuo Dong, MD PhD, Chi Wai Eric So, PhD

Blood (2006) 108 (11): 360.

https://doi.org/10.1182/blood.V108.11.360.360

Published: 2006

Journal Articles

Assessment of mechanism of acquired skewed X inactivation by analysis of twins

Mark A. Vickers, Ewan McLeod, Timothy D. Spector, Ian J. Wilson

Blood (2001) 97 (5): 1274–1281.

https://doi.org/10.1182/blood.V97.5.1274

Published: 2001

Journal Articles

Oxidants, ATP depletion, and endothelial permeability to macromolecules

J Wilson, M Winter, DM Shasby

Blood (1990) 76 (12): 2578–2582.

https://doi.org/10.1182/blood.V76.12.2578.2578

Published: 1990

Journal Articles

Comparison of 6-Mercaptopurine and Busulfan in Chronic Granulocytic Leukemia

SOUTHEASTERN CANCER CHEMOTHERAPY COOPERATIVE STUDY GROUP, CHARLES M. HUGULEY, JR., M.D., JAMES GRIZZLE, Ph.D., R. WAYNE RUNDLES, M.D., WARREN N. BELL, M.D., CHARLES C. CORLEY, JR., M.D., W. B. FROMMEYER, JR., M.D., B. G. GREENBERG, Ph.D., WILLIAM HAMMACK, M.D., JOHN C. HERION, M.D., G. WATSON JAMES, III, M.D., WILLIAM E. LARSEN, M.D., VIRGIL LOEB, M.D., LOUIS A. LEONE, M.D., JEFFRESS G. PALMER, M.D., SLOAN J. WILSON, M.D.

Blood (1963) 21 (1): 89–101.

https://doi.org/10.1182/blood.V21.1.89.89

Published: 1963

Journal Articles

Blood Coagulation in Acute Iron Intoxication

SLOAN J. WILSON, HELEN E. HEATH, PAUL L. NELSON, G. GEORGE ENS

Blood (1958) 13 (5): 483–491.

https://doi.org/10.1182/blood.V13.5.483.483

Published: 1958

NARROW

Bomedemstat (IMG-7289), an LSD1 Inhibitor, Manages the Signs and Symptoms of Essential Thrombocythemia (ET) While Reducing the Burden of Cells Homozygous for Driver Mutations

Real World, Single-Centre Experience of Pregnancy in Patients with Philadelphia Negative Myeloproliferative Neoplasms

The Use of Targeted RNA- Sequencing Assay in the Diagnostic Evaluation of Acute Myeloid Leukaemia(AML)

Chromoanagenesis in Haematological Malignancy: Review of Samples from Patients with Acute Leukemia and MDS

A Real World, Single-Centre Study of Young Adult Patients with Philadelphia Negative Myeloproliferative Neoplasms

A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET)

The Use of Avapritinib in Advanced Systemic Mastocytosis: Report of an Open-Label Compassionate Use Program in the United Kingdom

Single Centre Analysis of JAK2 V617F and Exon 12 Negative Idiopathic Erythrocytosis

EDIT-301: An Experimental Autologous Cell Therapy Comprising Cas12a-RNP Modified mPB-CD34+ Cells for the Potential Treatment of SCD

Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation Model

Inhibiting TGFβ Signaling in CAR T-Cells May Significantly Enhance Efficacy of Tumor Immunotherapy

Design, Optimization, and Pre-Clinical Evaluation of Direct, Mechanism-Based STAT3 Inhibitors for Treating Myeloid Disorders

Dysregulation of the Imprinted DLK1-DIO3 Locus in Promyelocytic Leukemia

Hoxa9 Suppresses Cellular Senescence and Sustains the Development of Leukemic Stem Cells Induced by Fusion Proteins In the Absence of Bmi1.

FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection

Recruitment of RXRα by Homo-Oligomeric RARα Is a Key for RARα-Mediated Transformation.

Assessment of mechanism of acquired skewed X inactivation by analysis of twins

Oxidants, ATP depletion, and endothelial permeability to macromolecules

Comparison of 6-Mercaptopurine and Busulfan in Chronic Granulocytic Leukemia

Blood Coagulation in Acute Iron Intoxication

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only